TAMs facilitate immune evasion by secreting IL-10, inducing T cell apoptosis via CD120a/b (27, 28), altering tumor cell phenotypes, and overexpressing B7-H3 via EGFR/MAPK, inhibiting CD8+ T cells (29). The gene discussed is CD8A; the disease is neoplasm.